Scientists at the National Institute on Drug Abuse (NIDA) have demonstrated that laboratory animals will self-administer marijuana's psychoactive component, THC (delta-9-tetrahydrocannabinol), in doses equivalent to those used by humans who smoke the drug. Self-administration of drugs by animals, long considered a model of human drug-seeking behavior, is characteristic of virtually all addictive and abused drugs.
In a companion piece, this Vidyya contains an informative guide on marijuana for parents. The guide is from the National Institute on Drug Abuse and can be freely copied and distributed.
In other news, over the past 14 months, AIDS treatment
activists, many of whom are members of The HIV Immune Based Therapy Working
Group have placed pressure on the Food and Drug Administration regarding the
FDA process, procedures and review of immune based therapies for the treatment of HIV disease. In a surprise turn of events by the FDA Antiviral Committee, a meeting took place yesterday to discuss these issues.
In research news, scientists will be better able to fight Burkitt's lymphoma, a rare but deadly cancer that attacks children and AIDS patients, now that they have achieved a decades-long goal of genetically engineering mice to develop the disease.
Also on the subject of lymphoma, you can catch up on a month's reading in one place with abstracts from the last 30 days, all of which focus on the therapy of Non-Hodgkin's lymphoma. Topics cover salvage therapy, new clinical trial results and more.
The articles in today's Vidyya are:
As always, we hope you enjoy the issue.